Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
18 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-presents-two-posters-for-tivozanib-at-the-2025-asco-gu-meeting-302377714.html
12 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-announces-tivozanib-presentations-at-asco-gu-2025-302374155.html
16 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-present-tinivo-2-results-and-tivo-3-exploratory-post-immunotherapy-survival-analysis-at-esmo-2024-302248624.html
03 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-announces-acceptance-of-late-breaking-oral-presentation-of-tinivo-2-results-at-esmo-2024-302235507.html
13 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/lg-chem-company-and-aveo-oncology-announce-lg-chems-first-proprietary-anti-cancer-compound-enters-phase-1-clinical-study-dosing-initiated-in-the-us-302171565.html
27 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-announces-completion-of-enrollment-in-pivotal-phase-3-tinivo-2-study-of-fotivda-tivozanib-in-combination-with-opdivo-nivolumab-in-advanced-renal-cell-carcinoma-301864465.html
ABOUT THIS PAGE